Page 35 - Johnson Medtech News Today

Limerick are the hurling champions of Ireland this year, but the county is certainly no slouch when it comes to tech either.

The new branding capitalizes the "C" in "healthcare" (i.e. GE HealthCare), demonstrating support of both better health and better care.

One of its projects will create trusted data access and enable data sharing between eye healthcare system stakeholders.

Good Day Atlanta viewer information for July 1, 2022

The Series A funding will enable completion of the development of the company's unique co-manipulative surgical robotic product and prepare it for a successful commercial launch.PARIS, FRANCE and SAN FRANCISCO

Johnson & Johnson refuses to provide Livingstone Hospital with orthopaedic implants over R34-million in unpaid invoices.

Johnson & Johnson MedTech's DePuy Synthes announced today that its Inhance system has received FDA clearance for total shoulder arthroplasty.

Johnson & Johnson, which will split in two, names a new CEO and CFO of the future New Consumer Health Company.

In its 2022 annual report, New Brunswick health care giant Johnson & Johnson announced its medical devices division would be rebranded as Johnson & Johnson MedTech.

AdmIRE study will evaluate safety and effectiveness of investigational Pulse Field Ablation (PFA) technologies in treating symptomatic drug refractory recurrent intermittent atrial fibrillation.